Annual FCF
$22.06 B
-$2.19 B-9.02%
31 December 2023
Summary:
AbbVie annual free cash flow is currently $22.06 billion, with the most recent change of -$2.19 billion (-9.02%) on 31 December 2023. During the last 3 years, it has risen by +$5.27 billion (+31.40%). ABBV annual FCF is now -9.02% below its all-time high of $24.25 billion, reached on 31 December 2022.ABBV Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$5.20 B
+$3.17 B+156.06%
30 September 2024
Summary:
AbbVie quarterly free cash flow is currently $5.20 billion, with the most recent change of +$3.17 billion (+156.06%) on 30 September 2024. Over the past year, it has dropped by -$2.16 billion (-29.33%). ABBV quarterly FCF is now -32.65% below its all-time high of $7.72 billion, reached on 30 September 2021.ABBV Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$15.62 B
-$2.16 B-12.13%
30 September 2024
Summary:
AbbVie TTM free cash flow is currently $15.62 billion, with the most recent change of -$2.16 billion (-12.13%) on 30 September 2024. Over the past year, it has dropped by -$9.11 billion (-36.82%). ABBV TTM FCF is now -37.00% below its all-time high of $24.80 billion, reached on 30 June 2023.ABBV TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABBV Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.0% | -29.3% | -36.8% |
| 3 y3 years | +31.4% | -32.6% | -27.9% |
| 5 y5 years | +72.5% | +18.1% | +20.8% |
ABBV Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.0% | +31.4% | -32.6% | +156.1% | -37.0% | at low |
| 5 y | 5 years | -9.0% | +72.7% | -32.6% | +156.1% | -37.0% | +22.3% |
| alltime | all time | -9.0% | +651.2% | -32.6% | +811.1% | -37.0% | +1218.5% |
AbbVie Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.20 B(+156.1%) | $15.62 B(-12.1%) |
| June 2024 | - | $2.03 B(-47.2%) | $17.78 B(-18.8%) |
| Mar 2024 | - | $3.85 B(-15.4%) | $21.89 B(-0.8%) |
| Dec 2023 | $22.06 B(-9.0%) | $4.55 B(-38.2%) | $22.06 B(-10.8%) |
| Sept 2023 | - | $7.36 B(+19.8%) | $24.73 B(-0.3%) |
| June 2023 | - | $6.14 B(+52.8%) | $24.80 B(+5.4%) |
| Mar 2023 | - | $4.02 B(-44.3%) | $23.52 B(-3.0%) |
| Dec 2022 | $24.25 B(+10.3%) | $7.21 B(-2.8%) | $24.25 B(+10.6%) |
| Sept 2022 | - | $7.42 B(+52.7%) | $21.92 B(-1.3%) |
| June 2022 | - | $4.86 B(+2.4%) | $22.21 B(+0.8%) |
| Mar 2022 | - | $4.75 B(-2.9%) | $22.05 B(+0.3%) |
| Dec 2021 | $21.99 B(+31.0%) | $4.89 B(-36.7%) | $21.99 B(+1.4%) |
| Sept 2021 | - | $7.72 B(+64.4%) | $21.68 B(+10.8%) |
| June 2021 | - | $4.70 B(+0.1%) | $19.57 B(+10.0%) |
| Mar 2021 | - | $4.69 B(+2.5%) | $17.79 B(+5.9%) |
| Dec 2020 | $16.79 B(+31.5%) | $4.58 B(-18.5%) | $16.79 B(+9.5%) |
| Sept 2020 | - | $5.61 B(+92.8%) | $15.33 B(+8.6%) |
| June 2020 | - | $2.91 B(-21.1%) | $14.12 B(+4.2%) |
| Mar 2020 | - | $3.69 B(+18.6%) | $13.55 B(+6.1%) |
| Dec 2019 | $12.77 B(-0.1%) | $3.11 B(-29.3%) | $12.77 B(-1.2%) |
| Sept 2019 | - | $4.40 B(+87.4%) | $12.93 B(+1.2%) |
| June 2019 | - | $2.35 B(-19.3%) | $12.77 B(-3.1%) |
| Mar 2019 | - | $2.91 B(-11.0%) | $13.17 B(+3.0%) |
| Dec 2018 | $12.79 B(+35.6%) | $3.27 B(-22.9%) | $12.79 B(+7.3%) |
| Sept 2018 | - | $4.24 B(+54.1%) | $11.92 B(+10.1%) |
| June 2018 | - | $2.75 B(+8.9%) | $10.82 B(+8.8%) |
| Mar 2018 | - | $2.53 B(+5.2%) | $9.95 B(+5.5%) |
| Dec 2017 | $9.43 B | $2.40 B(-23.6%) | $9.43 B(+11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $3.15 B(+67.6%) | $8.46 B(+27.1%) |
| June 2017 | - | $1.88 B(-6.5%) | $6.65 B(+1.4%) |
| Mar 2017 | - | $2.01 B(+40.6%) | $6.56 B(0.0%) |
| Dec 2016 | $6.56 B(-6.3%) | $1.43 B(+6.4%) | $6.56 B(-5.6%) |
| Sept 2016 | - | $1.34 B(-25.0%) | $6.95 B(-9.0%) |
| June 2016 | - | $1.79 B(-11.0%) | $7.64 B(+0.9%) |
| Mar 2016 | - | $2.01 B(+10.4%) | $7.57 B(+8.1%) |
| Dec 2015 | $7.00 B(+138.4%) | $1.82 B(-10.4%) | $7.00 B(+57.2%) |
| Sept 2015 | - | $2.03 B(+18.1%) | $4.45 B(+10.5%) |
| June 2015 | - | $1.72 B(+19.2%) | $4.03 B(+3.7%) |
| Mar 2015 | - | $1.44 B(-297.0%) | $3.89 B(+32.4%) |
| Dec 2014 | $2.94 B(-49.2%) | -$731.00 M(-145.5%) | $2.94 B(-38.3%) |
| Sept 2014 | - | $1.61 B(+2.0%) | $4.76 B(-1.2%) |
| June 2014 | - | $1.57 B(+223.4%) | $4.82 B(-6.6%) |
| Mar 2014 | - | $487.00 M(-55.5%) | $5.16 B(-10.6%) |
| Dec 2013 | $5.78 B(-3.9%) | $1.09 B(-34.3%) | $5.78 B(+4.5%) |
| Sept 2013 | - | $1.67 B(-13.2%) | $5.53 B(-9.8%) |
| June 2013 | - | $1.92 B(+74.5%) | $6.13 B(+7.9%) |
| Mar 2013 | - | $1.10 B(+29.9%) | $5.68 B(-5.5%) |
| Dec 2012 | $6.01 B(+2.1%) | $846.00 M(-62.7%) | $6.01 B(-1.6%) |
| Sept 2012 | - | $2.27 B(+54.5%) | $6.11 B(+10.1%) |
| June 2012 | - | $1.47 B(+2.4%) | $5.55 B(-9.6%) |
| Mar 2012 | - | $1.43 B(+51.7%) | $6.14 B(+4.2%) |
| Dec 2011 | $5.89 B(+30.1%) | $943.91 M(-44.7%) | $5.89 B(+19.1%) |
| Sept 2011 | - | $1.71 B(-17.0%) | $4.95 B(+52.6%) |
| June 2011 | - | $2.06 B(+73.5%) | $3.24 B(+173.5%) |
| Mar 2011 | - | $1.18 B | $1.18 B |
| Dec 2010 | $4.53 B(-10.4%) | - | - |
| Dec 2009 | $5.05 B | - | - |
FAQ
- What is AbbVie annual free cash flow?
- What is the all time high annual FCF for AbbVie?
- What is AbbVie annual FCF year-on-year change?
- What is AbbVie quarterly free cash flow?
- What is the all time high quarterly FCF for AbbVie?
- What is AbbVie quarterly FCF year-on-year change?
- What is AbbVie TTM free cash flow?
- What is the all time high TTM FCF for AbbVie?
- What is AbbVie TTM FCF year-on-year change?
What is AbbVie annual free cash flow?
The current annual FCF of ABBV is $22.06 B
What is the all time high annual FCF for AbbVie?
AbbVie all-time high annual free cash flow is $24.25 B
What is AbbVie annual FCF year-on-year change?
Over the past year, ABBV annual free cash flow has changed by -$2.19 B (-9.02%)
What is AbbVie quarterly free cash flow?
The current quarterly FCF of ABBV is $5.20 B
What is the all time high quarterly FCF for AbbVie?
AbbVie all-time high quarterly free cash flow is $7.72 B
What is AbbVie quarterly FCF year-on-year change?
Over the past year, ABBV quarterly free cash flow has changed by -$2.16 B (-29.33%)
What is AbbVie TTM free cash flow?
The current TTM FCF of ABBV is $15.62 B
What is the all time high TTM FCF for AbbVie?
AbbVie all-time high TTM free cash flow is $24.80 B
What is AbbVie TTM FCF year-on-year change?
Over the past year, ABBV TTM free cash flow has changed by -$9.11 B (-36.82%)